A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 2072928)

Published in Mol Endocrinol on May 01, 1991

Authors

M T Tusie-Luna1, P W Speiser, M Dumic, M I New, P C White

Author Affiliations

1: Division of Pediatric Endocrinology, Cornell University Medical College, New York 10021.

Articles citing this

The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev (2010) 4.95

Neonatal screening for congenital adrenal hyperplasia. Nat Rev Endocrinol (2009) 1.40

Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest (1992) 1.40

Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab (2007) 1.34

Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab (2009) 1.33

Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A (2013) 1.31

Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia. Proc Natl Acad Sci U S A (2013) 1.28

The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency. Clin Biochem Rev (2009) 1.08

Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci U S A (1999) 1.05

Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc Natl Acad Sci U S A (1992) 0.96

Direct molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia. J Med Genet (1996) 0.91

Genotype-phenotype correlation in 27 pediatric patients in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in a single center. Ann Pediatr Endocrinol Metab (2013) 0.89

Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update. Steroids (2011) 0.82

Characterisation of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene. J Med Genet (1997) 0.79

Function and membrane topology of wild-type and mutated cytochrome P-450c21. Biochem J (1996) 0.78

Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia. Indian J Endocrinol Metab (2012) 0.78

Evolutionary origin of mutations in the primate cytochrome P450c21 gene. Am J Hum Genet (1992) 0.78

Congenital adrenal hyperplasia. Dermatoendocrinol (2009) 0.78

Research Resource: Correlating Human Cytochrome P450 21A2 Crystal Structure and Phenotypes of Mutations in Congenital Adrenal Hyperplasia. Mol Endocrinol (2015) 0.77

Prevalence of nonclassic congenital adrenal hyperplasia in Turkish children presenting with premature pubarche, hirsutism, or oligomenorrhoea. Int J Endocrinol (2014) 0.76

Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia. Adv Biomed Res (2015) 0.75

Direct Molecular Diagnosis of CYP21A2 Point Mutations in Macedonian and Serbian Patients with 21-Hydroxylase Deficiency. J Med Biochem (2014) 0.75

Articles by these authors

Chemical characterization of a neural cell adhesion molecule purified from embryonic brain membranes. J Biol Chem (1982) 5.87

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev (2000) 3.99

Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci U S A (1985) 3.22

HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A (1984) 2.56

High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet (1985) 2.44

Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci U S A (1986) 2.34

Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab (2001) 2.01

Evaluation of a new assay for Vi antibody in chronic carriers of Salmonella typhi. J Clin Microbiol (1980) 1.90

Cloning and expression of cDNA encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A (1984) 1.89

Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab (1983) 1.77

A new form of congenital adrenal hyperplasia. J Clin Endocrinol Metab (1967) 1.72

Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). J Biol Chem (1989) 1.69

Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab (1977) 1.69

Nonelectrolyte diffusion across lipid bilayer systems. J Gen Physiol (1976) 1.59

Two steroid 21-hydroxylase genes are located in the murine S region. Nature (1985) 1.58

Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype. Am J Hum Genet (2000) 1.58

Persistence of Mycobacterium bovis in cattle. Trends Microbiol (1994) 1.56

Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J Biol Chem (1989) 1.54

Frequent deletion and duplication of the steroid 21-hydroxylase genes. Am J Hum Genet (1986) 1.54

A waterborne outbreak of gastroenteritis in adults associated with Escherichia coli. Lancet (1968) 1.53

Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein. J Clin Endocrinol Metab (1986) 1.52

Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations. J Clin Endocrinol Metab (1999) 1.52

Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab (1995) 1.51

Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet (1996) 1.51

Time course of recovery of adrenal function in children treated for leukemia. J Pediatr (2000) 1.51

Mutation in the CYP21B gene (Ile-172----Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A (1988) 1.50

Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet (1995) 1.50

Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation (1999) 1.48

Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest (1992) 1.40

Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A (1988) 1.40

Recent advances in 21-hydroxylase deficiency. Annu Rev Med (1984) 1.39

Vi serology in the detection of typhoid carriers. Lancet (1981) 1.39

Congenital adrenal hyperplasia. (1). N Engl J Med (1987) 1.36

HLA linkage and B14, DR1, BfS haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency. Am J Hum Genet (1981) 1.35

A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics (1992) 1.33

The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J Biol Chem (1991) 1.33

Prenatal diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency) by HLA typing. Lancet (1979) 1.30

Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem (1990) 1.27

Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1. N Engl J Med (1988) 1.26

Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction. Genomics (1995) 1.26

Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group. N Engl J Med (1978) 1.25

The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol (1991) 1.24

Congenital adrenal hyperplasia (2). N Engl J Med (1987) 1.24

Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci U S A (1992) 1.23

Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics (1986) 1.23

Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes. Proc Natl Acad Sci U S A (1988) 1.23

Serum androgens as a continuing index of adequacy of treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab (1978) 1.22

Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency. Pediatr Res (1984) 1.20

Gender change from female to male in classical congenital adrenal hyperplasia. Horm Behav (1996) 1.20

Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci U S A (1995) 1.20

A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest (1991) 1.20

Neurological and adrenal dysfunction in the adrenal insufficiency/alacrima/achalasia (3A) syndrome. Arch Dis Child (1993) 1.17

Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci U S A (1987) 1.17

Tyr-179 and Lys-183 are essential for enzymatic activity of 11 beta-hydroxysteroid dehydrogenase. Biochem Biophys Res Commun (1992) 1.16

Nonsense mutation causing steroid 21-hydroxylase deficiency. J Clin Invest (1988) 1.15

Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci U S A (1993) 1.14

Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab (2001) 1.14

Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab (1995) 1.14

Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics (2001) 1.13

A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab (1979) 1.12

Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. J Clin Invest (1970) 1.12

Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation (1998) 1.12

Diet-hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in man. Life Sci (1987) 1.10

The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH). Acta Endocrinol Suppl (Copenh) (1986) 1.10

A pilot newborn screening for congenital adrenal hyperplasia in Alaska. J Clin Endocrinol Metab (1982) 1.10

Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci U S A (1992) 1.09

Steroidogenic enzyme gene expression in the human heart. J Clin Endocrinol Metab (2000) 1.08

Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology (1995) 1.08

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab (2006) 1.08

Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab (1998) 1.08

Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme. Biochemistry (1994) 1.08

Nucleotide sequence analysis of murine 21-hydroxylase genes: mutations affecting gene expression. Proc Natl Acad Sci U S A (1986) 1.07

Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol (1997) 1.07

Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1. J Clin Endocrinol Metab (1999) 1.06

Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab (1996) 1.06

Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3 alpha-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol (1993) 1.06

"Acquired" adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorders as congenital adrenal hyperplasia. J Clin Endocrinol Metab (1979) 1.05

Aldosterone excretion in normal children and in children with adrenal hyperplasia. J Clin Invest (1966) 1.05

Complement C4 allotypes in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: further evidence for different allelic variants at the 21-hydroxylase locus. Clin Immunol Immunopathol (1982) 1.03

Progressive adrenal failure in polyglandular autoimmune disease. J Clin Endocrinol Metab (1982) 1.03